 develop cirrhosi chronic type hepat clinicopatholog follow-up studi hbeag-posit asymptomat patient rate hbeag clearanc outcom patient asymptomat chronic hepat viru hbv infect condit yr mean mean age yr male chronic hepat biopsi posit hbcag hepatocyt alcohol homosexu drug abus immunocompromis patient advanc liver diseas follow-up patient hbeag seroneg hbv-dnap estim annual rate seroconvers patient hbsag seroconvers patient evid liver diseas biopsi clinic follow-up biopsi second liver biopsi avail patient hbcag neg histolog normal unchang compat cirrhosi clinic and/or biochem evid advanc liver diseas start studi activ hepat necrosi initi biopsi earli identif patient silent chronic hbv infect high level viral replic antivir therapi transmiss infect progress cirrhosi hepatocellular carcinoma